Dr. Pieramici is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
5555 Business Park
Ste 100
Bakersfield, CA 93309Phone+1 661-325-4393Fax+1 661-322-8489- Is this information wrong?
Summary
- Dr. Dante Pieramici is an ophthalmologist in Santa Barbara, CA and is affiliated with multiple hospitals in the area, including Community Memorial Hospital, Goleta Valley Cottage Hospital, Providence Saint John's Health Center, and Santa Barbara Cottage Hospital. He received his medical degree from Johns Hopkins University School of Medicine and has been in practice 26 years. He specializes in retinal disease and is experienced in retina surgery, general / comprehensive ophthalmology, vitreoretinal disease, and pediatric retinal disease.
Education & Training
- Johns Hopkins UniversityResidency, Ophthalmology, 1992 - 1995
- University of Chicago (NorthShore)Internship, Transitional Year, 1991 - 1992
- Johns Hopkins University School of MedicineClass of 1991
Certifications & Licensure
- CA State Medical License 2001 - 2024
- MD State Medical License 1996 - 2005
- CT State Medical License 1997 - 1998
- GA State Medical License 1995 - 1997
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Top Doctors:LA Area Castle Connolly, 2013
- Top Doctors:Southern California Castle Connolly, 2012
- Fellow (FAAO) American Academy of Ophthalmology
Clinical Trials
- Lucentis for Central Retinal Vein Occlusion (CRVO) Start of enrollment: 2006 Jan 01
- Bevacizumab in Combination With Visudyne Photodynamic Therapy (PDT) Start of enrollment: 2006 May 01
- Lucentis for Macular Edema Associated With Central Retinal Vein Occlusion Start of enrollment: 2010 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsGene therapy for neovascular age-related macular degeneration by subretinal delivery of RGX-314: a phase 1/2a dose-escalation study.Robert Avery, David M Brown, Jeffrey S Heier, Stephen Pakola, Charles C Wykoff, Sherri Van Everen, Peter A Campochiaro, Allen C Ho, Stephen M Huddleston, Glenn J Jaffe...> ;Lancet. 2024 Mar 27
- 2 citationsSafety and efficacy of ixoberogene soroparvovec in neovascular age-related macular degeneration in the United States (OPTIC): a prospective, two-year, multicentre phas...Boyer, D., Wykoff, C., Busbee, B., Danzig, C., Joondeph, B., Major, J., Turpcu, A., Kiss, S., Khanani, A., Regillo, C., Pieramici, D.> ;Eclinicalmedicine. 2024 Jan 1
- X-Ray Vision during Iodine-125 Plaque Radiation Treatment of a Choroidal Melanoma.Kevin R Card, Dante J Pieramici> ;Ophthalmology. Retina. 2022 Aug 1
- Join now to see all
Authored Content
- The Port Delivery System with RanibizumabMarch 2019
Press Mentions
- Adverum Biotechnologies Presents Anatomical Improvements in Intraretinal and Subretinal Fluid After a Single IVT Injection of Ixo-Vec (ADVM-022) in the OPTIC Study in Wet AMDOctober 1st, 2022
- Effect of Initial Management with Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients with Diabetic Macular Edema Involving the Center of the Macula and Good Visual AcuityMay 1st, 2019
- The Port Delivery System with RanibizumabMarch 1st, 2019
- Join now to see all
Professional Memberships
- Fellow
Hospital Affiliations
- Community Memorial HospitalVentura, California
- Goleta Valley Cottage HospitalSanta Barbara, California
- Providence Saint John's Health CenterSanta Monica, California
- Santa Barbara Cottage HospitalSanta Barbara, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: